SEC Form D filing

Bio Usawa Inc., 2025-12-17

An SEC Form D private-offering notice from San Francisco, CA, a $1,705,000 filer-stated offering target in Biotech. Filed 2025-12-17. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Bio Usawa Inc. site↗ Verified via SEC Form D

Biotechnology company developing and manufacturing affordable monoclonal antibody biosimilars, initially for cancer, for patients in Africa.

Filed 2025-12-17Filed to raise $1,705,000First money in 2024-02-21Raised so far $1,705,000HQ (as filed) San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified biousawa.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • Bio Usawa Inc., 2025-12-17, $404K EDGAR↗
  • Bio Usawa Inc., 2025-12-17, $1.7M EDGAR↗
  • Bio Usawa Inc., 2025-12-17, Undisclosed EDGAR↗

Other Form D filings from the same week

each with its own page and its own EDGAR source